Reply to Kesici et al. and Zeng et al.: Blocking the virus and reducing the inflammatory damage in COVID-19
- PMID: 32398377
- PMCID: PMC7293643
- DOI: 10.1073/pnas.2007408117
Reply to Kesici et al. and Zeng et al.: Blocking the virus and reducing the inflammatory damage in COVID-19
Conflict of interest statement
The authors declare no competing interest.
Comment on
-
Get rid of the bad first: Therapeutic plasma exchange with convalescent plasma for severe COVID-19.Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):12526-12527. doi: 10.1073/pnas.2006691117. Epub 2020 May 12. Proc Natl Acad Sci U S A. 2020. PMID: 32398378 Free PMC article. No abstract available.
-
Convalescent plasma for patients with COVID-19.Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):12528. doi: 10.1073/pnas.2006961117. Epub 2020 May 12. Proc Natl Acad Sci U S A. 2020. PMID: 32398379 Free PMC article. No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
